Investigating how MeCP2 interacts with DNA in the brain
Single-molecule Investigation of the Interaction Between MeCP2 and Chromatin
This study is looking at how a protein called MeCP2 interacts with DNA in brain cells, which is important for understanding Rett syndrome, a condition caused by changes in the MeCP2 gene, and it hopes to find new ways to help treat this disorder.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rockefeller University NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10913516 on NIH RePORTER |
What this research studies
This research focuses on understanding the interaction between the MeCP2 protein and methylated DNA, which is crucial for proper neuronal function. By using advanced techniques like fluorescence microscopy and optical trapping, the study aims to observe how MeCP2 navigates the complex structure of DNA within cells. This could provide insights into the mechanisms behind Rett syndrome, a severe neurological disorder caused by mutations in the MeCP2 gene. The findings may help identify new therapeutic strategies to address the underlying causes of this condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are females diagnosed with Rett syndrome, particularly those with known mutations in the MeCP2 gene.
Not a fit: Patients without Rett syndrome or those with other unrelated neurological disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of targeted therapies for Rett syndrome, improving outcomes for affected individuals.
How similar studies have performed: While the specific approach of single-molecule investigation is novel, previous research has shown that understanding protein-DNA interactions can lead to significant advancements in treating genetic disorders.
Where this research is happening
New York, United States
- Rockefeller University — New York, United States (Active)
Researchers
- Principal investigator: Chua, Gabriella N. L. — Rockefeller University
- Study coordinator: Chua, Gabriella N. L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.